H.C. Wainwright raised the firm’s price target on Core Scientific (CORZ) to $17 from $15 and keeps a Buy rating on the shares post the Q3 report. The firm says Core Scientific shifted its focus to high-performance computing, further expanding its infrastructure through its partnership with CoreWeave. The high-performance computing benefits spur infrastructure re-direction with more clients expected in the mid-term, the analyst tells investors in a research note.